Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Kleinpenning

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2016
[A young man with discoloured nails]H J Schers, M M Kleinpenning
Dermatology (Basel, Switzerland)|December 17, 2008
Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapyM J P Gerritsen, T Smits, M M Kleinpenning, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2011
Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative studyM M Kleinpenning, M E Otero, P E J van Erp, et al.
The British Journal of Dermatology|August 3, 2006
A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasisT Smits, M M Kleinpenning, P E J van Erp, et al.
The British Journal of Dermatology|August 17, 2006
Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical studyM M Kleinpenning, T Smits, E Ewalds, et al.
The British Journal of Dermatology|May 27, 2009
Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimensM M Kleinpenning, T Smits, J Boezeman, et al.
The British Journal of Dermatology|June 23, 2009
Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapyA W M Evers, M M Kleinpenning, T Smits, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2023
Exclusion by age, cardiovascular comorbidity and malignancies are the main factors that impact generalizability of evidence from trials to the real-world situation in older adults with psoriasisE L M Ter Haar, J M P A van den Reek, E E Ten Bruin, et al.
Drugs & Aging|July 21, 2022
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry StudyE L M Ter Haar, S E Thomas, J M P A van den Reek, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|July 21, 2016
[A young man with discoloured nails]H J Schers, M M Kleinpenning
Dermatology (Basel, Switzerland)|December 17, 2008
Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapyM J P Gerritsen, T Smits, M M Kleinpenning, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 26, 2011
Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative studyM M Kleinpenning, M E Otero, P E J van Erp, et al.
The British Journal of Dermatology|August 3, 2006
A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasisT Smits, M M Kleinpenning, P E J van Erp, et al.
The British Journal of Dermatology|August 17, 2006
Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical studyM M Kleinpenning, T Smits, E Ewalds, et al.
The British Journal of Dermatology|May 27, 2009
Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimensM M Kleinpenning, T Smits, J Boezeman, et al.
The British Journal of Dermatology|June 23, 2009
Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapyA W M Evers, M M Kleinpenning, T Smits, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2023
Exclusion by age, cardiovascular comorbidity and malignancies are the main factors that impact generalizability of evidence from trials to the real-world situation in older adults with psoriasisE L M Ter Haar, J M P A van den Reek, E E Ten Bruin, et al.
Drugs & Aging|July 21, 2022
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry StudyE L M Ter Haar, S E Thomas, J M P A van den Reek, et al.
Pageof 1